Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway

Abstract Objective Asthma is a prevalent status attributing to lower respiratory tract chronic inflammation. Azithromycin (AZM) is known to be effective against asthma. Thus, this study delved into the mechanism of AZM repressing airway remodeling (AR) via the SAPK/JNK pathway in asthma. Methods Sim...

Full description

Saved in:
Bibliographic Details
Main Authors: Dannv Ma, Huaqing Du, Yi Huang, Aiwu Pan, Lu Gan
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-024-03193-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559173362352128
author Dannv Ma
Huaqing Du
Yi Huang
Aiwu Pan
Lu Gan
author_facet Dannv Ma
Huaqing Du
Yi Huang
Aiwu Pan
Lu Gan
author_sort Dannv Ma
collection DOAJ
description Abstract Objective Asthma is a prevalent status attributing to lower respiratory tract chronic inflammation. Azithromycin (AZM) is known to be effective against asthma. Thus, this study delved into the mechanism of AZM repressing airway remodeling (AR) via the SAPK/JNK pathway in asthma. Methods Simulated asthmatic AR mouse model was developed by induction with ovalbumin (OVA) and intervened with AZM or dexamethasone (DEX) and anisomycin (JNK activator). Pathological changes in mouse lung tissues and AR were assessed by HE and Masson staining. The numbers of inflammatory cells, macrophages, eosinophils, neutrophils and lymphocytes in bronchoalveolar lavage fluid (BALF) were detected by Diff-Quik staining. Inflammatory factor levels (IL-6, TNF-α, IL-4) in BALF, and Collagen I, Collagen III, SAPK/JNK and p-SAPK/JNK protein levels in lung tissues were measured by ELISA and Western blot. Results The OVA-led asthmatic mouse model was successfully established. Relative to the OVA group, AZM and DEX treatment improved pulmonary smooth muscle thickening and bronchial epithelial fibrosis, reduced inflammatory cells, macrophages, eosinophils, neutrophils and lymphocytes in BALF, inhibited inflammatory factor TNF-α, IL-6, and IL-4 levels in BALF, and down-regulated Collagen I, Collagen III, and p-SAPK/JNK protein levels in lung tissues, with no prominent difference between the two regimens. JNK activator partially reversed the protective effect of AZM against OVA-induced asthma in mice. Conclusion AZM alleviated airway inflammation by inhibiting the SAPK/JNK pathway, thereby repressing AR in asthmatic mice. This study provided partial theoretical basis for clarifying asthma pathogenesis and new ideas for treating asthma.
format Article
id doaj-art-ccac9b8e782c4d1fb52317122ce4c269
institution Kabale University
issn 1749-8090
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj-art-ccac9b8e782c4d1fb52317122ce4c2692025-01-05T12:45:55ZengBMCJournal of Cardiothoracic Surgery1749-80902024-12-011911910.1186/s13019-024-03193-wStudy of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathwayDannv Ma0Huaqing Du1Yi Huang2Aiwu Pan3Lu Gan4Department of Internal Medicine, the Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Internal Medicine, the Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Internal Medicine, the Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Internal Medicine, the Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Internal Medicine, the Second Affiliated Hospital, Zhejiang University School of MedicineAbstract Objective Asthma is a prevalent status attributing to lower respiratory tract chronic inflammation. Azithromycin (AZM) is known to be effective against asthma. Thus, this study delved into the mechanism of AZM repressing airway remodeling (AR) via the SAPK/JNK pathway in asthma. Methods Simulated asthmatic AR mouse model was developed by induction with ovalbumin (OVA) and intervened with AZM or dexamethasone (DEX) and anisomycin (JNK activator). Pathological changes in mouse lung tissues and AR were assessed by HE and Masson staining. The numbers of inflammatory cells, macrophages, eosinophils, neutrophils and lymphocytes in bronchoalveolar lavage fluid (BALF) were detected by Diff-Quik staining. Inflammatory factor levels (IL-6, TNF-α, IL-4) in BALF, and Collagen I, Collagen III, SAPK/JNK and p-SAPK/JNK protein levels in lung tissues were measured by ELISA and Western blot. Results The OVA-led asthmatic mouse model was successfully established. Relative to the OVA group, AZM and DEX treatment improved pulmonary smooth muscle thickening and bronchial epithelial fibrosis, reduced inflammatory cells, macrophages, eosinophils, neutrophils and lymphocytes in BALF, inhibited inflammatory factor TNF-α, IL-6, and IL-4 levels in BALF, and down-regulated Collagen I, Collagen III, and p-SAPK/JNK protein levels in lung tissues, with no prominent difference between the two regimens. JNK activator partially reversed the protective effect of AZM against OVA-induced asthma in mice. Conclusion AZM alleviated airway inflammation by inhibiting the SAPK/JNK pathway, thereby repressing AR in asthmatic mice. This study provided partial theoretical basis for clarifying asthma pathogenesis and new ideas for treating asthma.https://doi.org/10.1186/s13019-024-03193-wAzithromycinAsthmaAirway remodelingAirway inflammationStress activated protein kinases/C-jun N-terminal kinases
spellingShingle Dannv Ma
Huaqing Du
Yi Huang
Aiwu Pan
Lu Gan
Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
Journal of Cardiothoracic Surgery
Azithromycin
Asthma
Airway remodeling
Airway inflammation
Stress activated protein kinases/C-jun N-terminal kinases
title Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
title_full Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
title_fullStr Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
title_full_unstemmed Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
title_short Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
title_sort study of the effect of azithromycin on airway remodeling in asthma via the sapk jnk pathway
topic Azithromycin
Asthma
Airway remodeling
Airway inflammation
Stress activated protein kinases/C-jun N-terminal kinases
url https://doi.org/10.1186/s13019-024-03193-w
work_keys_str_mv AT dannvma studyoftheeffectofazithromycinonairwayremodelinginasthmaviathesapkjnkpathway
AT huaqingdu studyoftheeffectofazithromycinonairwayremodelinginasthmaviathesapkjnkpathway
AT yihuang studyoftheeffectofazithromycinonairwayremodelinginasthmaviathesapkjnkpathway
AT aiwupan studyoftheeffectofazithromycinonairwayremodelinginasthmaviathesapkjnkpathway
AT lugan studyoftheeffectofazithromycinonairwayremodelinginasthmaviathesapkjnkpathway